Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Beckham-Backed Prenetics Pivots Away From Bitcoin Accumulation Strategy in 2026
Prenetics Global Limited, the Nasdaq-listed health sciences firm partnered with David Beckham, has officially concluded its aggressive cryptocurrency acquisition program. As of early 2026, the company has suspended all future Bitcoin purchases and will redirect capital previously earmarked for digital assets back toward core business expansion. The shift marks a significant strategic recalibration for the organization, which had amassed approximately 510 BTC (valued at roughly $45 million at the time of the halt) through its “1 BTC per day” buying initiative launched in August 2025.
Market Volatility Forces Crypto Treasury Rethink
The decision emerged against a backdrop of substantial cryptocurrency market turbulence in the final months of 2025. Bitcoin experienced considerable downside pressure during this period, triggering a broader reassessment among public companies holding digital assets. The vulnerability of equity-funded crypto strategies became particularly evident when examining peer performance. MicroStrategy, a prominent advocate of Bitcoin treasury accumulation, saw its equity decline more than 60% over a six-month window—a steeper loss than Bitcoin itself endured. This divergence illustrated the leverage and compounding risks inherent in coupling corporate balance sheets with volatile asset classes.
The reputational and governance challenges linked to such positions were not lost on market observers and corporate boards alike. Prenetics’ leadership and board unanimously agreed that the current market environment warranted a strategic recalibration, prioritizing stability and operational focus over digital asset expansion.
IM8 Health Brand Accelerates, Beckham Partnership Gains Momentum
The redirection of capital aligns with extraordinary momentum in Prenetics’ health and nutrition venture, IM8. The brand, developed in collaboration with David Beckham, has achieved $100 million in annualized recurring revenue within just 11 months of launch—a remarkable achievement that has captured investor attention and shaped board priorities. Management expects the brand to reach between $160 million and $200 million in revenue during 2026.
CEO Danny Yeung articulated the rationale: “Operating from a position of strength, we are making disciplined strategic decisions that reflect our experience as operators and our commitment to maximizing long-term shareholder value.” The exceptional performance of the IM8 line positioned health and nutrition market expansion as the more compelling use of capital, relative to further Bitcoin accumulation.
Prenetics will retain its existing Bitcoin holdings as a strategic reserve but has committed to halting new purchases. Following the announcement, the company’s stock experienced a 3.5% pullback. However, PRE has delivered substantial gains of 189% throughout 2025, underscoring underlying investor confidence despite the tactical adjustment.
Broader Retreat: When Public Companies Reconsider Crypto Exposure
Prenetics is not navigating this transition in isolation. A discernible trend has emerged across the corporate landscape as firms reassess the role of digital assets in their treasury strategies. ETHZilla, a venture backed by investment authority Peter Thiel, recently liquidated $74.5 million in Ethereum holdings and dismantled its cryptocurrency treasury operations entirely. These moves reflect a pragmatic recognition among institutional investors and corporate leadership that, while digital assets offer certain strategic benefits, the volatility and reputational risks may outweigh the upside, particularly during market corrections.
Prenetics’ decision to prioritize IM8 and suspend Bitcoin purchases represents a maturing approach to corporate capital allocation. The firm remains among a select group of non-crypto enterprises maintaining meaningful digital asset reserves, but the pivot toward organic growth in the health sciences sector signals a recalibration of risk tolerance across the boardroom. For stakeholders, the message is clear: brand-driven operational excellence, exemplified by the Beckham partnership’s success, now takes precedence over passive digital asset accumulation.